Cameron Turtle is Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE). The company reported total compensation of $6,707,361 for fiscal year 2025.
| Salary | $665,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $5,552,886 |
| Non-equity incentive plan | $475,475 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $6,707,361 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Spyre Therapeutics, Inc. filed April 10, 2026, accession 0001636282-26-000039.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $665,000 | $0 | $0 | $5,552,886 | $475,475 | $0 | $14,000 | $6,707,361 |
| FY2024 | Chief Executive Officer | $625,000 | $0 | $0 | $5,914,353 | $412,500 | $0 | $8,333 | $6,960,186 |
| FY2023 | Chief Executive Officer | $272,850 | $141,000 | $0 | $15,500,492 | $0 | $0 | $5,203 | $15,919,545 |
Totals as disclosed in each year's own compensation disclosure for Spyre Therapeutics, Inc..
| Peer-group chief executive median | $6,374,138 |
|---|---|
| Difference from that median | $333,223 |
| Percentile within the disclosed peer group | 60th |
| Peers with a disclosed figure | 14 |
Medians and percentiles are computed across the peer group Spyre Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Cameron Turtle this page | Chief Executive Officer | $6,707,361 |
| Sheldon Sloan | Chief Medical Officer | $2,211,805 |
| Scott Burrows | Chief Financial Officer | $2,192,045 |
| Heidy King-Jones | Chief Legal Officer and Corporate Secretary | $2,192,045 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Spyre Therapeutics, Inc. compensation brief.
Cameron Turtle's compensation sits inside Spyre Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.